Connor, Clark & Lunn Investment Management (CC&L)’s Agios Pharmaceuticals AGIO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16.8M | Buy |
505,225
+118,702
| +31% | +$3.95M | 0.06% | 279 |
|
|
2025
Q1 | $11.3M | Buy |
386,523
+260,845
| +208% | +$7.64M | 0.05% | 296 |
|
|
2024
Q4 | $4.13M | Buy |
125,678
+103,405
| +464% | +$3.4M | 0.02% | 531 |
|
|
2024
Q3 | $990K | Sell |
22,273
-15,008
| -40% | -$667K | ﹤0.01% | 893 |
|
|
2024
Q2 | $1.61M | Buy |
+37,281
| New | +$1.61M | 0.01% | 715 |
|
|
2024
Q1 | – | Sell |
-10,131
| Closed | -$226K | – | 1505 |
|
|
2023
Q4 | $226K | Buy |
+10,131
| New | +$226K | ﹤0.01% | 1241 |
|
|
2023
Q3 | – | Sell |
-80,083
| Closed | -$2.27M | – | 1341 |
|
|
2023
Q2 | $2.27M | Sell |
80,083
-42,451
| -35% | -$1.2M | 0.01% | 578 |
|
|
2023
Q1 | $2.81M | Sell |
122,534
-29,608
| -19% | -$680K | 0.02% | 483 |
|
|
2022
Q4 | $4.27M | Sell |
152,142
-41,333
| -21% | -$1.16M | 0.02% | 383 |
|
|
2022
Q3 | $5.47M | Buy |
193,475
+51,820
| +37% | +$1.47M | 0.04% | 310 |
|
|
2022
Q2 | $3.14M | Buy |
141,655
+32,767
| +30% | +$726K | 0.02% | 399 |
|
|
2022
Q1 | $3.17M | Buy |
108,888
+23,410
| +27% | +$682K | 0.02% | 402 |
|
|
2021
Q4 | $2.81M | Sell |
85,478
-18,645
| -18% | -$613K | 0.01% | 455 |
|
|
2021
Q3 | $4.81M | Buy |
104,123
+77,943
| +298% | +$3.6M | 0.03% | 347 |
|
|
2021
Q2 | $1.44M | Buy |
26,180
+17,616
| +206% | +$971K | 0.01% | 610 |
|
|
2021
Q1 | $442K | Buy |
+8,564
| New | +$442K | ﹤0.01% | 807 |
|